We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Stockal+Disclaimer.pdf
19 own
28 watching
Current Price
$6.05
$0.65
(12.04%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
1,077.95M
52-Week High
6.46000
52-Week Low
1.58000
Average Volume
2.91M
Dividend Yield
--
P/E Ratio
84.6746
Market Capitalization1,077.95M52-Week High6.4600052-Week Low1.58000Average Volume2.91MDividend Yield--P/E Ratio84.6746What does the Stockal+Disclaimer.pdf do?
Amneal Pharmaceuticals, Inc., formerly known as Atlas Holdings, Inc. (the "Company"), was formed along with its wholly owned subsidiary, K2 Merger Sub Corporation, a Delaware corporation ("Merger Sub"), on October 4, 2017, for the purpose of facilitating the combination of Impax Laboratories, Inc. (now Impax Laboratories, LLC), a Delaware corporation then listed on the Nasdaq Stock Market ("Impax") and Amneal Pharmaceuticals LLC, a Delaware limited liability company ("Amneal").
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
TipRanks Financial Blog
9 months ago
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amneal Pharmaceuticals (AMRX Research Report), Replimune Group ... Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amneal Pharmaceuticals (AMRX Research Report), Replimune Group...
PR Newswire
9 months ago
Thinking about buying stock in Oncolytics Biotech, Eos Energy Enterprises, Rivian Automotive, Carnival Corp, or Amneal Pharmaceuticals? Thinking about buying stock in Oncolytics Biotech, Eos Energy Enterprises, Rivian Automotive, Carnival Corp, or Amneal Pharmaceuticals? PR Newswire NEW YORK, July...
Business Wire
9 months ago
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (Amneal or the Company) today announced the launch of its authorized generic for Xyrem1 (Sodium Oxybate) oral solution CIII in the United States. Sodium Oxybate oral solution, 0.5 g/mL is a central nervous system depressant indicated for the treatment of...
Business Wire
9 months ago
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (Amneal or the Company) today announced it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the Companys New Drug Application (NDA) for IPX203 for the treatment of Parkinsons disease. The letter...
Tickeron - Stocks
9 months ago
This is a signal that AMRX's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
Can Indians buy Stockal+Disclaimer.pdf shares?
How can I buy Stockal+Disclaimer.pdf shares from India?
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
What is today’s traded volume of Stockal+Disclaimer.pdf?
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
Current Price
$6.05
$0.65
(12.04%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.